Contact this trialFirst, we need to learn more about you.
Proteasome Inhibitor
Mezigdomide Combo vs. Pomalidomide Combo for Multiple Myeloma
Recruiting2 awardsPhase 3
Hattiesburg, Mississippi
This trial is testing a new combo - CC-92480, bortezomib, and dexamethasone - against the standard of care - pomalidomide, bortezomib, and dexamethasone - for patients with multiple myeloma who have failed 1-3 prior treatments and have been treated with lenalidomide before.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.